Straumann Group expands presence in China building its first manufacturing, education and innovation center

  • Plans to invest up to 1.2 billion Chinese yuan (~CHF 170 million) in the Straumann Group’s China Campus by 2029
  • Expansion caters to rapidly growing demands of Chinese dentists and patients for dental solutions
  • Campus to ensure responsiveness and support forthcoming launches in China

Shanghai, 26 March 2021 – The Straumann Group, a global leader in implant and esthetic dentistry, signed an investment agreement with the Shanghai Xin Zhuang Industrial Park (SHXIP) to establish its first Campus in China comprising a manufacturing, education and innovation center at one site. With an investment of up to 1.2 billion Chinese yuan by 2029, the China Campus will provide various educational programs as well as products from the Group’s implant and orthodontics portfolio for China, catering to the rapidly growing demands of Chinese dentists and patients for dental solutions.


“China has become one of the leaders and front runners of dental treatment and innovation worldwide. We are excited about strengthening our presence to meet the fast-growing demand of dentists and patients for dental solutions in China”, said CEO Guillaume Daniellot. “This investment demonstrates our commitment to our continued contribution to the health of the Chinese people.”


It is estimated that currently China has over 700 million patients who need dental and oral care, but only 5% visit dental clinics1.To significantly improve the Chinese public’s oral health literacy and behaviors is outlined as a goal in China's Oral Health Action Plan (2019-2025). Meanwhile, despite the lack of reimbursement, orthodontics have become one of the most in-demand treatments, especially in urban and developed areas.


“Building the Straumann Group China Campus not only demonstrates our commitment to bringing dental solutions to dentists and their patients in China, it also enables us to increase responsiveness and will support forthcoming product launches”, commented Kevin Zhang, Vice President and Country Manager China and added: “Our new China Campus will be part of the Shanghai Xin Zhuang Industrial Park (SHXIP),a technology cluster in Shanghai which houses a lot of excellent innovation platforms, providing many opportunities for future collaboration with local partners helping to accelerate digitalization.“


The first phase of the investment is planned to be completed in autumn 2023. By 2029 the China Campus is expected to generate potentially more than 1000 new job opportunities.



About Straumann

The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, biomaterials and digital solutions for use in tooth replacement and restoration or to prevent tooth loss.


Headquartered in Basel, Switzerland, the Group currently employs more than 7300 people worldwide and its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.




Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland.

Phone: +41 (0)61 965 11 11





Corporate Communication

Silvia Dobry:               +41 (0)61 965 15 62

Jana Erdmann:          +41 (0)61 965 12 39




Investor Relations

Marcel Kellerhals:         +41 (0)61 965 17 51



This release contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Straumann Group to differ materially from those expressed or implied in this release. The Group is providing the information in this release as of this date and does not undertake any obligation to update any statements contained in it as a result of new information, future events or otherwise.

# # #


12019 China Health Statistical Yearbook